Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Cytori Therapeutics (CYTX) Scleroderma Day Offers Compelling Data - Maxim Group
-
Juno Therapeutics (JUNO) JCAR014 ASH Data Impressive But Cerebral Edema Could be a Concern - Maxim Group
-
High VCN Number at ASH Bodes Well for bluebird bio (BLUE) - Maxim Group
-
Maxim Group Maintains Bullish View on Kite Pharma (KITE) Amid First BLA for CAR-T
-
Streetinsider.com's Hot Lunchtime Reads 12/2: (FNMA) (SRPT) (GALE) (NVCN)
-
Galena Biopharma (GALE) PT Raised to $4 at Maxim Group into San Antonio Breast Cancer Symposium
-
Streetinsider.com's Hot Lunchtime Reads 12/1: (ANGI) (CAT) (BLUE) (SRPT)
-
bluebird bio (BLUE) PT Raised to $87 at Maxim Group
-
Genetic Technologies (GENE) Enters $6M ADS Direct Offering
-
Genetic Technologies Announces Offering of USD 6.0 Million of American Depository Shares
-
Maxim Group Starts Alarm.com (ALRM) at Buy
-
Notable Analyst Rating Changes 11/30: (UNH) (CE) (GS) Upgraded; (GRA) (FCX) (DLTH) Downgraded
-
Maxim Group Downgrades ManTech (MANT) to Hold
-
Maxim Group Starts SciClone Pharmaceuticals (SCLN) at Buy
-
Maxim Group Downgrades Darden Restaurants (DRI) to Hold
-
Maxim Group Downgrades Cracker Barrel (CBRL) to Hold
-
IntelliPharmaCeutics (IPCI) Rexista NDA Filing Expected, But 'Very Good News' - Maxim Group
-
Rosetta Genomics (ROSG) Prices of $5M Concurrent Registered Direct and Private Placement
-
Rosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering
-
Juno Therapeutics (JUNO) PT Lowered to $34 at Maxim Group
-
Maxim Group Downgrades Capnia (CAPN) to Hold
-
Maxim Group Starts Navigator Holdings Ltd. (NVGS) at Buy
-
Seanergy Maritime (SHIP) Prices 1.3M Share Registered Direct Offering at $2.75/Share
-
Seanergy Maritime Holdings Corp. Announces Pricing of $3.6 Million Registered Direct Offering
-
Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million
-
Maxim Group Downgrades NetApp (NTAP) to Hold
-
PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.
-
2017 Seen as a Challenge for Teva (TEVA), But Sticking with 'Buy' - Maxim
-
Xtant Medical Announces Expiration of Rights Offering and Estimated Gross Proceeds of $3.8 Million
-
Maxim Group Upgrades Cheesecake Factory (CAKE) to Buy
-
Sucampo Pharmaceuticals (SCMP) PT Raised to $19 at Maxim Group
-
Xtant Medical Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period and Final Subscription Price
-
Maxim Group Downgrades ImmunoCellular Therapeutics (IMUC) to Hold
-
ImmunoCellular Therapeutics Announces Third Quarter 2016 Financial Results and Provides Research and Development Update
-
Maxim Group Downgrades Biostage (BSTG) to Hold
-
Maxim Group Downgrades Celsion Corp (CLSN) to Hold
-
Notable Analyst Rating Changes 11/10: (HUM) (IBM) (WFT) Upgraded; (AXL) (BEN) (VTR) Downgraded
-
Maxim Group Starts Proteon Therapeutics (PRTO) at Buy
-
Maxim Group Starts Amedica Corporation (AMDA) at Buy
-
Minimum wage hikes in four states show path for labor under Trump
-
Maxim Group Upgrades Keryx Biopharmaceuticals (KERX) to Buy
-
Xtant Medical Announces Adjustment to Subscription Price of Rights Offering
-
Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Applied DNA Sciences Closes on $5 Million Private Placement
-
Notable Analyst Rating Changes 11/7: (PAH) (BIIB) (CMI) Upgraded; (GPRO) (PNR) (BMRN) Downgraded
-
Maxim Group Upgrades Potbelly Corp (PBPB) to Buy
-
HSN, Inc. to Participate in the Maxim Group Consumer Technology Conference
-
Applied DNA Sciences Announces $5 Million Private Placement
-
Maxim Group Upgrades Quotient Technology (QUOT) to Buy
-
Aeterna Zentaris Announces Closing of US$7,560,000 Registered Direct Offering of Common Shares and Warrants

